Infant Gut Health Market Surges Toward USD 15.55 Billion by 2032 as North America Leads With 34.5% Share and Nestlé Dominates With 17.8% Global Presence

The global infant gut health market reached US$8,321.01 million in 2023, rising to US$8,920.13 million in 2024 and is expected to reach US$15,557.12 million by 2032, growing at a CAGR of 7.2% from 2025 to 2032., according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, Abbott Laboratories expanded its U.S. probiotic infant formula line with a new Bifidobacterium-enriched variant, partnering with major pediatric networks to support colic relief, reducing symptoms by 20% in clinical trials.

✅ In September 2025, Reckitt Benckiser Group launched a prebiotic HMO-infused drop for newborns, certified for immune support and distributed via CVS amid rising parental awareness of microbiome health.

✅ In August 2025, BioGaia AB introduced a synbiotic powder for constipation management, compliant with FDA guidelines and available through Amazon for e-commerce-driven accessibility.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):
https://www.datamintelligence.com/download-sample/infant-gut-health-market?sindhuri

Japan: Recent Industry Developments

✅ In October 2025, Chr. Hansen A/S adopted advanced fermentation tech in its Japanese facilities, enhancing postbiotic stability by 18% for diarrhea-preventing supplements exported to Asia-Pacific.

✅ In September 2025, PROBI AB collaborated with local maternity clinics to develop a liquid probiotic for immune support, focusing on low-allergen profiles under national pediatric health initiatives.

✅ In August 2025, Japan's Ministry of Health, Labour and Welfare subsidized microbiome research for 5,000 infant cases, supporting organic prebiotic innovations in drugstores.

Asia-Pacific: Recent Industry Developments

✅ In October 2025, Danone S.A. opened a new formulation plant in India for synbiotic infant drinks, supplying B2B clients in pharmacies with constipation-relief blends.

✅ In September 2025, i-Health Inc. imported record volumes of HMO-prebiotics from Europe, driven by urban demand for gut health kits during festive parenting seasons in China.

✅ In August 2025, Nestlé S.A. launched a powder-based postbiotic for colic in Southeast Asia, integrating with e-commerce for targeted immune and digestive support.

Market Trends & Drivers

The Global Infant Gut Health Market is thriving due to surging demand for microbiome-supporting products amid rising digestive issues (e.g., 70-85% regurgitation, 17-40% constipation, 10-40% colic), expanding applications in probiotics, prebiotics, and synbiotics for diarrhea management, immune support, and overall development, and increasing parental awareness around early nutrition's role in lifelong health. Key trends include innovation in formats (e.g., drops for easy dosing, HMO-enriched formulas), growth in sustainable sourcing (organic, eco-packaged synbiotics), and increasing adoption in preventive care (digital tracking apps, clinical-backed strains). The rise of e-commerce for baby wellness, premiumization in emerging markets, and regulatory pushes for pediatric claims (FDA/EFSA approvals, WHO microbiome guidelines) are significantly accelerating market expansion amid shifting preferences for gentle, evidence-based, and accessible infant gut solutions.

Speak to Our Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/infant-gut-health-market?sindhuri

Competitive Landscape

The market is moderately consolidated among European, North American, and Asia-Pacific producers, with intense competition in strain innovation, clinical validation, and retail accessibility.

» Nestlé S.A. dominates globally with approximately 17.8% share, leveraging its vertically integrated probiotic formulas for digestive and immune applications across food, beverage, and supplement platforms.

» Danone S.A. holds around 15.2% share, leading in synbiotic beverages and Human-Milk-Oligosaccharide (HMO)-enriched options for infant colic, constipation relief, and digestive support worldwide.

» Abbott Laboratories commands roughly 11.4% share, excelling in powder-based prebiotic and probiotic systems for U.S. pediatric and adult markets, focusing on organic and clean-label positioning.

» Reckitt Benckiser Group plc holds about 9.7% share, specializing in liquid probiotic drops for immune support, with strong e-commerce and wellness channel presence.

» BioGaia AB secures nearly 8.9% share, driving European growth with patented Bifidobacterium and Lactobacillus strains developed for diarrhea management and pediatric health.

» PROBI AB maintains close to 7.1% share, innovating in postbiotic powders and targeting high-growth Asian export markets with allergen-free and functional-dosage formats.

» Chr. Hansen A/S holds approximately 6.5% share, focusing on fermentation technologies and sustainable synbiotic platforms for emerging markets including APAC and Latin America.

» i-Health Inc. holds around 5.3% share, targeting B2B pharmacies with affordable HMO- and probiotic-kit solutions tailored to busy urban parents and tele-medicine channels.

» Amway Corp. controls about 4.6% share, strengthening its global position with premium gut-wellness drops and multi-strain probiotic systems for affluent health-conscious consumers.

» Yili Group commands approximately 4.0% share, pioneering regional launches of formula-integrated probiotics within China, leveraging local dairy ecosystems and export-capable manufacturing.

✦ Upcoming Key Player - Seed Health Inc.
Estimated to capture ~2% of future share growth, Seed Health is a U.S.-based microbiome science startup developing dual-strain synbiotics and scalable direct-to-consumer prescription-grade formulations. It is positioned for acquisitions or partnerships with larger global players.

Buy now and enjoy a 30% year-end discount - limited-time offer!
https://www.datamintelligence.com/buy-now-page?report=infant-gut-health-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)

Segmentation

☛ By Product Type

The Infant Gut Health Market is segmented into Probiotics, Prebiotics, Postbiotics, and Others.

Probiotics hold about 45.3% share, driven by strong acceptance in infant diarrhea, immunity, and microbiome support.

Prebiotics account for approximately 27.8% share, growing rapidly due to synergy with beneficial bacteria in formulas.

Postbiotics make up about 14.6% share, gaining traction for infant digestive and immune formulations.

Others hold around 12.3% share, covering synbiotics, HMOs, and emerging microbiome-targeted technologies.

☛ By Form
The market is divided into Liquid, Powder, and Others.
Powder leads with roughly 53.7% share, as it offers easy mixing with formula, longer shelf-life, and convenience for caregivers.

Liquid holds about 32.1% share, expanding due to drop/dose formats appealing to on-the-go parents.

Others (e.g., sachets, sticks) make up around 14.2% share, used for specialty feeding formats and prenatal-to-infant bridging products.

☛ By Application
Applications include Diarrhea Management, Constipation Management, Immune Support, and Others.
Immune Support dominates with around 40.5% share, fueled by increasing focus on early-life immunity post-pandemic.

Constipation Management accounts for about 22.4% share, growing with synbiotic innovations for digestive comfort.

Diarrhea Management holds approximately 19.8% share, driven by probiotic use in dysbiosis and acute GI events in infants.

Others represent roughly 17.3% share, including colic relief, allergy support, and microbiome-targeted growth formulations.

☛ By Distribution Channel
Distribution channels include Supermarkets & Hypermarkets, Pharmacies/Drug Stores, Online Retail, Specialty Stores, and Others.
Supermarkets & Hypermarkets lead with around 39.2% share, offering mass-market access for infant nutrition and gut health products.

Pharmacies/Drug Stores account for roughly 29.6% share, where premium and clinically backed formulas are prescribed or recommended.

Online Retail holds about 21.4% share, growing rapidly through subscription models and e-commerce convenience.

Specialty Stores represent about 6.5% share, focusing on organic, boutique, and premium infant wellness formulations.

Others (~3.3% share) include institutional procurement, nursery supply chains, and direct-to-consumer club channels.

Regional Analysis

» North America dominates the global Infant Gut Health Market, accounting for 34.5% of the total share in 2024, driven by strong consumer awareness, high purchasing power, established pediatric care systems, and widespread acceptance of probiotic-enriched infant formulas across the U.S. and Canada.

» Europe holds a significant market presence with a 27.2% share, supported by strict EFSA-backed product approvals, rising preference for organic and clean-label formulations, and strong adoption of prebiotics and synbiotics in countries such as Germany, France, and the UK-particularly for allergy and immune system development.

» Asia-Pacific is the fastest-growing region with a 23.9% market share, fueled by expanding infant populations in China, India, Japan, and Southeast Asia, increasing urbanization, and strong demand for affordable gut health solutions, especially synbiotic powders and sachets.

» South America holds about 8.1% of market share, driven by growing retail penetration in Brazil, Argentina, and Chile, with rising imports of liquid formats for immune support and colic management. E-commerce is accelerating market visibility and accessibility.

» The Middle East and Africa collectively represent approximately 6.3% share, showing emerging potential with rising healthcare investments, expanding pharmacies and modern retail formats, and increasing adoption of powdered microbiome-support products for digestive and immune benefits in infants.

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.